No Prescription |
 |
 | ||
|
Zipsydon Geodon |
|
| ||
No Prescription » Prescription Drugs 17 » Zipsydon Geodon This medication is used to treat certain mental/mood disorders (schizophrenia or manic/mixed episodes associated with bipolar disorder). It may be used after other medications have not been effective. Ziprasidone is a psychiatric medication (anti-psychotic type) that works by helping to restore the balance of certain natural substances (neurotransmitters) in the brain.This medication can make you feel less nervous and improve your concentration. It helps you to think more clearly and take a more active part in everyday life.OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.This drug has also been used to treat dementia-related behavior problems (e.g. agitation aggression) when standard treatments (e.g. behavioral therapy cholinesterase inhibitors) have not been successful.How to use Ziprasidone HCl OralRead the Patient Information Leaflet available from your pharmacist. Consult your doctor or pharmacist if you have any questions.Take this medication by mouth usually twice daily or as directed by your doctor. Swallow the capsules whole with food. Your doctor may start you at a low dose and gradually increase your dose in order to lessen side effects such as drowsiness. Follow your doctor's instructions carefully. Your dosage is based on your medical condition and response to therapy.Do not stop taking ziprasidone without consulting your doctor even if you start to feel better. Some conditions may worsen if the medication is suddenly stopped.Use this medication regularly in order to get the most benefit from it. To help you remember use it at the same time(s) each day. It may take several weeks before you get the full benefit of this medication.Ziprasidone HCl Oral is used to treat the following:Schizophrenia Agitation associated with Schizophrenia Manic Phase of Manic-Depression Bipolar I Disorder with Most Recent Episode MixedZiprasidone HCl Oral may also be used to treat:Manic-Depression Additional Medications to Treat Depression Buy Zipsydon Geodon and other Prescription Drugs 17 products online at Medstore. Buy Online at Medstore - Click Here!
About Zipsydon Geodon: Product Type: Prescription Drugs 17 Zipsydon ( Geodon Generic Ziprasidone ) Zipsydon (Geodon Generic Ziprasidone) Geodon Generic Ziprasidone 20mg 50 Capsules 20mg 2 x 50 Capsules 40mg 100 (2 x 50)Capsules 40mg 50 Capsules 40mg 200(4 x 50) Capsules 60mg 2 x 50 Capsules 60mg 50 Capsules 80mg 30 Capsules 80mg 180(6 x 30) Capsules 80mg 90(3 x 30) Capsules Geodon Generic Ziprasidone Zipsydon
View more Prescription Drugs 17 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
